Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand ...

The farmers clashed with police near Hakimpet, while they were on their way to the Dudyal Mandal Revenue Officer's office in ...

India's pharmaceutical and meditech exports are expected to continue strong growth despite global economic slowdown, driven ...

Exports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal ...

The US FDA has declined to approve Zealand Pharma's dasiglucagon for hypoglycaemia in infants with congenital hyperinsulinism ...

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

Boehringer Ingelheim has rolled into an alliance with undruggable target specialist Circle Pharma, putting together a package ...

Some six years after picking up Seattle’s Universal Cells for $102 million, Astellas Pharma is opening a second location for ...

Roche Holding AG will add manufacturing capacity in China to serve the country’s growing market, making it the latest ...

After third-party manufacturing issues led to a December rejection of Zealand Pharma’s pediatric congenital hyperinsulinism (CHI) candidate, the Danish pharma’s latest snub seems to come down to ti | ...

The maker of pharmaceutical inputs and bulk drugs said there was no Form 483 observation after the USFDA inspection of its ...